However, we still have no knowledge of the signaling, cellular and biological mechanism of action of the mutations in CK2α and CK2β that are associated with OCNDS and POBINDS, respectively. This evidence concerns the gene CSNK2B and Poirier-Bienvenu neurodevelopmental syndrome.